Huang Yubei, Tong Zhongsheng, Chen Kexin, Wang Ying, Liu Peifang, Gu Lin, Liu Juntian, Yu Jinpu, Song Fengju, Zhao Wenhua, Shi Yehui, Li Hui, Xiao Huaiyuan, Hao Xishan
Department of Epidemiology and Statistics.
Medicine Department of Breast Oncology.
Cancer Biol Med. 2019 Nov;16(4):825-835. doi: 10.20892/j.issn.2095-3941.2019.0322.
Breast cancer is the most common malignant tumor in Chinese women. Early screening is the best way to improve the rates of early diagnosis and survival of breast cancer patients. The peak onset age for breast cancer in Chinese women is considerably younger than those in European and American women. It is imperative to develop breast cancer screening guideline that is suitable for Chinese women. By summarizing the current evidence on breast cancer screening in Chinese women, and referring to the latest guidelines and consensus on breast cancer screening in Europe, the United States, and East Asia, the China Anti-Cancer Association and National Clinical Research Center for Cancer (Tianjin Medical University Cancer Institute and Hospital) have formulated population-based guideline for breast cancer screening in Chinese women. The guideline provides recommendations on breast cancer screening for Chinese women at average or high risk of breast cancer according to the following three aspects: age of screening, screening methods, and screening interval. This article provides more detailed information to support the recommendations in this guideline and to provide more direction for current breast cancer screening practices in China.
乳腺癌是中国女性中最常见的恶性肿瘤。早期筛查是提高乳腺癌患者早期诊断率和生存率的最佳途径。中国女性乳腺癌的发病高峰年龄比欧美女性要年轻得多。制定适合中国女性的乳腺癌筛查指南势在必行。通过总结中国女性乳腺癌筛查的现有证据，并参考欧美及东亚地区乳腺癌筛查的最新指南和共识，中国抗癌协会和国家癌症中心（天津医科大学肿瘤医院）制定了中国女性基于人群的乳腺癌筛查指南。该指南从筛查年龄、筛查方法和筛查间隔这三个方面，为处于平均或高乳腺癌风险的中国女性提供乳腺癌筛查建议。本文提供了更详细的信息，以支持本指南中的建议，并为中国目前的乳腺癌筛查实践提供更多指导。
